BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 18824553)

  • 1. Costs and cost-effectiveness of different follow-up schedules for detection of occupational hepatitis C virus infection.
    Deuffic-Burban S; Abiteboul D; Lot F; Branger M; Bouvet E; Yazdanpanah Y
    Gut; 2009 Jan; 58(1):105-10. PubMed ID: 18824553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. European recommendations for the management of healthcare workers occupationally exposed to hepatitis B virus and hepatitis C virus.
    Puro V; De Carli G; Cicalini S; Soldani F; Balslev U; Begovac J; Boaventura L; Campins Martí M; Hernández Navarrete MJ; Kammerlander R; Larsen C; Lot F; Lunding S; Marcus U; Payne L; Pereira AA; Thomas T; Ippolito G;
    Euro Surveill; 2005 Oct; 10(10):260-4. PubMed ID: 16282641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Favorable outcome of acute occupational hepatitis C in healthcare workers: a multicenter French study on 23 cases.
    Morin T; Pariente A; Lahmek P;
    Eur J Gastroenterol Hepatol; 2011 Jun; 23(6):515-20. PubMed ID: 21537126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for hepatitis C virus infection among Egyptian healthcare workers in a national liver diseases referral centre.
    Abdelwahab S; Rewisha E; Hashem M; Sobhy M; Galal I; Allam WR; Mikhail N; Galal G; El-Tabbakh M; El-Kamary SS; Waked I; Strickland GT
    Trans R Soc Trop Med Hyg; 2012 Feb; 106(2):98-103. PubMed ID: 22197011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features and progression of perinatally acquired hepatitis C virus infection.
    Resti M; Jara P; Hierro L; Azzari C; Giacchino R; Zuin G; Zancan L; Pedditzi S; Bortolotti F
    J Med Virol; 2003 Jul; 70(3):373-7. PubMed ID: 12766999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risk factors for hepatitis C virus transmission to Health Care Workers after occupational exposure: a European case-control study].
    Yazdanpanah Y; De Carli G; Migueres B; Lot F; Campins M; Colombo C; Thomas T; Deuffic-Burban S; Prevot MH; Domart M; Tarantola A; Abiteboul D; Deny P; Pol S; Desenclos JC; Puro V; Bouvet E
    Rev Epidemiol Sante Publique; 2006 Jul; 54 Spec No 1():1S23-1S31. PubMed ID: 17073127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of hepatitis C RNA and serum alanine aminotransferase in hepatitis B and C seronegative healthy blood donors.
    Ali N; Moiz B; Moatter T; Ahmed S; Adil SN; Khurshid M
    Indian J Pathol Microbiol; 2010; 53(3):480-5. PubMed ID: 20699507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C screening strategies in hemodialysis patients.
    Saab S; Brezina M; Gitnick G; Martin P; Yee HF
    Am J Kidney Dis; 2001 Jul; 38(1):91-7. PubMed ID: 11431187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effectiveness and cost-effectiveness of screening for hepatitis C virus infection.
    Sroczynski G; Esteban E; Conrads-Frank A; Schwarzer R; Mühlberger N; Wright D; Zeuzem S; Siebert U
    Eur J Public Health; 2009 Jun; 19(3):245-53. PubMed ID: 19196737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of hepatitis C virus (HCV) RNA and anti-HCV results and evaluation of the relationship between transaminase levels].
    Kaşifoğlu N; Us T; Akgün Y
    Mikrobiyol Bul; 2007 Oct; 41(4):557-63. PubMed ID: 18173074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of hepatitis C virus markers and hepatitis C virus genomic-RNA after needlestick accidents.
    Sodeyama T; Kiyosawa K; Urushihara A; Matsumoto A; Tanaka E; Furuta S; Akahane Y
    Arch Intern Med; 1993 Jul; 153(13):1565-72. PubMed ID: 7686741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [HCV RNA testing for early diagnosis of hepatitis C in blood donors--new challenge for transfusion medicine and hepatology].
    Brojer E; Letowska M; Gronowska A; Kubicka-Russel D; Liszewski G; Grabarczyk P; Medyńska J; Mikulska K; Sabliński J
    Pol Merkur Lekarski; 2004 Oct; 17(100):321-5. PubMed ID: 15690692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing of hepatitis C antiviral therapy in patients with advanced liver disease: a decision analysis model.
    Saab S; Hunt DR; Stone MA; McClune A; Tong MJ
    Liver Transpl; 2010 Jun; 16(6):748-59. PubMed ID: 20517909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: long-term predictors from a community-based cohort study.
    Lee MH; Yang HI; Lu SN; Jen CL; Yeh SH; Liu CJ; Chen PJ; You SL; Wang LY; Chen WJ; Chen CJ
    J Clin Oncol; 2010 Oct; 28(30):4587-93. PubMed ID: 20855826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
    Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
    Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The spectrum of chronic hepatitis C virus infection in the Virginia Correctional System: development of a strategy for the evaluation and treatment of inmates with HCV.
    Sterling RK; Brown RS; Hofmann CM; Luketic VA; Stravitz RT; Sanyal AJ; Contos MJ; Mills AS; Smith V; Shiffman ML
    Am J Gastroenterol; 2005 Feb; 100(2):313-21. PubMed ID: 15667488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Quality of care and health economics in occupationally acquired hepatitis C in German health care workers between 1993 and 2004].
    Reiser M; Haverkamp A; Dintsios M; Mölleken C; Krauth C; Pieper W; Schmiegel W
    Dtsch Med Wochenschr; 2007 Aug; 132(34-35):1743-7. PubMed ID: 17713882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low levels of awareness, vaccine coverage, and the need for boosters among health care workers in tertiary care hospitals in India.
    Sukriti ; Pati NT; Sethi A; Agrawal K; Agrawal K; Kumar GT; Kumar M; Kaanan AT; Sarin SK
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1710-5. PubMed ID: 18761556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of hepatitis C viral RNA in anti-hepatitis C virus non- reactive blood donors with normal alanine aminotransferase.
    Ali N; Moinuddin ; Ahmed SA; Chotani RA; Fisher-Hoch SP
    J Coll Physicians Surg Pak; 2010 Oct; 20(10):662-6. PubMed ID: 20943108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus infection as risk factor for mother-to-child hepatitis C virus transmission; persistence of anti-hepatitis C virus in children is associated with the mother's anti-hepatitis C virus immunoblotting pattern.
    Manzini P; Saracco G; Cerchier A; Riva C; Musso A; Ricotti E; Palomba E; Scolfaro C; Verme G; Bonino F
    Hepatology; 1995 Feb; 21(2):328-32. PubMed ID: 7843701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.